Author
@Amgen Amgen
Official Amgen corporate feed broadcasting first-party biopharma news and milestones
Publish authoritative corporate communications and IR announ
trader score
·
hit rate
·
mean α
·
signals 14d
2
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.
Their picks, scored
Not yet in the scored-bets universe (fewer than 20 scoreable calls). Their last-14d mentions, direction-adjusted, have moved -1.3% since posting (mean over 2 mentions with price data).
Recent signals2receipts included
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-08-27 | AMGN | @Amgen | +0.50 | Amgen directly announces positive top-line Phase 3 results in eosinophilic esophagitis. | -1.0% | tweet ↗ |
| 2026-08-21 | AMGN | @Amgen | +0.25 | Amgen describes continued work to improve LDL-cholesterol management based on long-term evidence. | -1.6% | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.